Co-administration of Pramlintide and Insulin Via an Automated Dual-hormone Artificial Pancreas System in Adults With Type 1 Diabetes

NCT04243629 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 1
Type 1 Diabetes
Postprandial Hyperglycemia

Interventions

DRUG: Rapid-Acting Insulin
DRUG: Placebo
DRUG: Pramlintide Acetate
DEVICE: Artificial Pancreas

Sponsor

McGill University

Collaborators

[object Object]